Purchase Order 75N92024P00129

The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $22,190 firm-fixed-price purchase order contract to Proteogenix, a for-profit biotechnology manufacturer based in France. The contract is for Proteogenix to provide a phage library to support NHLBI's Cellular and Molecular Therapeutics Laboratory's upcoming genetic analysis experiments, which are focused on developing hematopoietic stem cell (HSC) therapy with gene...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $15,440 firm fixed-price purchase order to Proteogenix, a biotechnology manufacturer based in Schiltigheim, France, on August 28, 2025. The contract, which utilizes no set-aside designation, requires delivery of a phage library to support the NHLBI's Cellular and Molecular Therapeutics Laboratory in conducting genetic analysis experiments. The phage library will facilitate the laboratory's ongoing research into hematopoietic stem...

The National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded a $10,620 firm fixed price purchase order to Proteogenix, a for-profit manufacturer of biotechnology products and services. The contract provides additional laboratory screening services to support the development of novel gene therapy by the NHLBI's Center for Molecular Therapeutics and Bioanalytics (CMTB). This award is not associated with a larger contract vehicle and does not have...

<p>The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $249,648.00 firm fixed price purchase order to Medical Neurogenetics, LLC, a for-profit organization, for clinical genetic testing services. The contract has a completion date of November 2, 2023 and does not have a set-aside designation. The place of performance is Bethesda, Maryland.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $21,600 firm fixed price purchase order to Hybrigenics Services of France. The contract is for HYBRIBODY: ASSAY SET UP IN VITRO/PHAGE DISPLAY + ELISA services under NIAID Ambis Project 2183487. Hybrigenics Services will perform the requested in vitro and phage display assay setup and ELISA services from August 8, 2023 through September 29, 2023 to support...

This is a $24,940 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Psomagen Inc., a for-profit genomics and molecular biology services company. The contract is to provide plasma protein detection services using a proteomics platform to support NHLBI's ongoing clinical protocol for sickle cell disease research. The contract period of performance is from June 15, 2025 to December 14, 2025. No set-aside designation was...

The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $19,000.00 firm fixed price purchase order contract to Hybrigenics Services, a for-profit organization. The contract was not set aside. Hybrigenics Services provides services related to the study of protein interactions and target identification for drugs, including yeast two-hybrid screening, phage display assay setup, ELISA services, library construction...

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $12,105.91 firm fixed price delivery order to Illumina, Inc. to provide DNA sequencing and genomics core requirements including Illumina library preparation kits. The place of performance is San Diego, California. The period of performance is from June 30, 2023 through September 29, 2023. The award supports the agency's biomedical research efforts by providing key...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price Definitive Contract to Adaptive Phage Therapeutics, Inc. to develop a rapid and scalable method for bacteriophage manufacture and purification under the Small Business Innovation Research (SBIR) Phase I program. The contract has a potential value of $296,787.00 and a completion date of August 15, 2022. This contract is not set...

<p>This is a firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Invivogen, a for-profit organization, for the delivery of biological and reagent materials. The contract has a ceiling value of $12,992.70 and a period of performance ending on March 3, 2026. This contract is not associated with a larger vehicle and does not have a set-aside designation. The NHGRI is the funding agency for this contract.</p>